FdaApplication
NDA 203697
Identifiers
- fda_app_no: NDA203697
Properties
| Property | Value |
|---|---|
| applicant_name | PLX PHARMA INC |
| application_type | NDA |
| approval_date | 2013-01-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VAZALORE | ASPIRIN | 81MG | CAPSULE;ORAL |
| VAZALORE | ASPIRIN | 325MG | CAPSULE;ORAL |
2 products